bibliographicCitation |
Intermesoli T, Castagnetti F, Soverini S, Bussini A, Spinelli O, Gnani A, Bassan R, Rosti G. Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib. Leuk Res. 2012 Jan;36(1):e10–1. doi: 10.1016/j.leukres.2011.09.002. PMID: 21962337. |